GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

RNST · Sep 30, 2024

RENASANT CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000715072-24-000186Bank
Sequential deposit growth70thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.79% · CORE · VALID

Net-income growth85thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

73.20% · CORE · VALID

Interest-income growth50thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

11.36% · CORE · VALID

Cash and equivalents80thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.3B · CORE · VALID

Sequential loan growth22thOwn-history percentile · N=18
Evidence method

Sequential · gp.financial.loans

0.18% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History37 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
0.13%
Current
1.79%
Delta
1.66%
Earnings Growth Increased
Previous
35.62%
Current
73.20%
Delta
37.58%
Interest Income Growth Decreased
Previous
11.69%
Current
11.36%
Delta
-0.33%
Liquidity Increased
Previous
$851.9M
Current
$1.3B
Delta
$423.7M
Loan Growth Decreased
Previous
0.86%
Current
0.18%
Delta
-0.68%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.